Can routine inpatient mortality data improve HIV mortality estimates? Inpatient mortality at an urban hospital in South Africa by Long, L C et al.
870       October 2018, Vol. 108, No. 10
RESEARCH
South Africa (SA) has a large generalised HIV epidemic, with >6 
million HIV-positive citizens and one of the world’s largest HIV 
treatment programmes, with ~3.9 million patients on treatment at 
the end of 2016.[1] Key indicators used to measure the success of this 
programme include an increase in life expectancy and a reduction in 
HIV-related mortality for patients on antiretroviral therapy (ART). 
SA has reported a steadily increasing life expectancy since 2006, and 
this has largely been attributed to the success of the national HIV 
programme.[2,3] HIV-related mortality is more difficult to measure, 
and as a result it has been difficult to accurately estimate and attribute 
the impact of the HIV programme on this indicator.
Mortality reporting in SA is managed by the Department of Home 
Affairs and governed by the Births and Deaths Registration Act 1992 
(Act No. 51 of 1992).[4] In 2013, Statistics South Africa (Stats SA) 
reported that 90% of all deaths were due to natural causes.[5] In 2011, 
they reported the percentage of mortality attributable to HIV to be 
3.4% (17 338/514 486), and they showed this percentage to increase 
between 2011 and 2013.[5] This is in contrast to the results of the 
Thembisa model, an integrated demographic and epidemiological 
model of the SA HIV/AIDS epidemic, which shows a decreasing 
percentage of deaths attributable to AIDS since 2005 with the 
introduction of antiretroviral treatment.[6] Thembisa estimates that in 
2011 there were 169 000 AIDS deaths, which would put the percentage 
of mortality attributable to HIV at almost 10 times that estimated in 
the Stats SA report (169 000/514 486 = 32%).[5,6] Bradshaw et al.[7] 
estimated that fewer than 10% (20 012/207 685) of deaths due to 
HIV/AIDS in 2010 were registered with HIV as the primary cause of 
death, which supports the discrepancy between the results of Stats SA 
and modelled estimates. The inconsistency between Deaths Registry 
data as reported by Stats SA, modelling estimates of HIV-attributable 
mortality and analyses of the registration data suggests that other 
sources of information are needed to understand the role of HIV in 
mortality as ART access expands.[8]
Data on the contribution of HIV to total mortality from sources 
other than the Deaths Registry are scarce. The majority of mortality 
with a known place of death occurs in hospitals. In 2010 and 2013, 
52% and 57%, respectively, of mortality with a known place of death 
occurred in hospitals.[5,9] A complementary approach to monitoring 
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Background. South Africa (SA) has one of the world’s largest HIV treatment programmes, to which a dramatic increase in life expectancy 
has been attributed. However, there continue to be concerns regarding the reporting of HIV-related mortality in SA, which varies by 
source. As accurate HIV mortality estimates are key to measuring the success of the national programme as well as identifying areas for 
improvement, we propose a complementary approach to monitoring changes in HIV-related mortality using routine inpatient records to 
examine trends in causes of death and HIV status over time.
Objectives. To investigate the feasibility of this approach by calculating mortality due to natural causes in the medical ward of a hospital 
during 2010 by HIV status.
Methods. We conducted a cross-sectional study of inpatient mortality at a regional hospital in Johannesburg, SA, analysing all deaths due 
to natural causes among adult medical ward inpatients. Cause of death was recorded from the mortuary register. HIV status was ascertained 
directly from the mortuary register or from laboratory tests specific for HIV diagnosis or monitoring.
Results. Of 1 167 inpatients who died, the majority were HIV-positive (58%). HIV positivity among males (55%) was slightly lower than 
that among females (61%), and HIV-positive patients were younger (median 40 years) than those who were HIV-negative (56 years) and of 
unknown HIV status (68 years). ‘Infections and parasites’ was the most common cause of natural death (29%). On average, HIV-positive 
patients were admitted for slightly longer (mean 10.5 days) than HIV-negative patients (9.6 days) and those of unknown HIV status 
(8.9 days), yet HIV-positive inpatient deaths accounted for the majority (62%) of the total bed days.
Conclusions. Even with widespread access to antiretroviral therapy, the majority of inpatient natural deaths at a large public sector hospital 
in 2010 were of HIV-positive patients and were probably related to HIV. In view of the importance of accurate data on causes of death, 
both for the HIV programme and to track other diseases, large-scale expansion of this approach over a longer period should be considered.
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changes in HIV-related mortality may be to use the relatively detailed 
information available from inpatient care records to examine trends 
in causes of death and HIV status over time.
Objectives
To investigate the feasibility of this approach by estimating mortality 
due to natural causes by HIV status in the medical ward of a large 
urban public sector hospital during 2010 using routine data.
Methods
Study population and data
We conducted a retrospective, cross-sectional study of inpatient 
mortality at a regional Gauteng Province Department of Health 
hospital in Johannesburg, SA. The hospital serves an urban population 
of both formal and informal settlements and has 11 inpatient medical 
wards with 347 beds.
The study population included all adult (≥18 years old) deaths 
due to natural causes (attributed to illness or an internal malfunction 
of the body) among patients admitted to a medical ward between 
1 January and 31 August 2010, an 8-month period intended to 
capture seasonal variation. Deaths from other (non-natural) causes 
(e.g. motor vehicle accident) or that occurred during admission to 
specialist wards (e.g. casualty, surgery) were excluded. Inpatient 
deaths that were missing the data required to determine study 
eligibility, such as date of admission, were excluded. Deaths of 
pregnant women were also excluded because pregnant women 
requiring admission were routinely referred to another hospital.
Cause of death and HIV status
All persons who die in hospital are taken to the hospital mortuary, 
where the details of death are recorded in the mortuary register. This 
register includes date of death, gender, age, date of admission, hospital 
ward and primary cause of death. In some instances, additional 
information about comorbid conditions potentially related to the cause 
of death is also recorded. SA classifies and codes deaths according 
to the 10th revision of the International Statistical Classification of 
Diseases and Related Health Problems (ICD-10).[9,10] We assigned 
a three-character ICD-10 code to each primary cause of death as 
recorded in the mortuary register. The study team did not have access 
to death certificates and could not distinguish between the immediate 
and underlying cause of death. If HIV was not included as part of the 
cause of death, then the cause of death was not attributed to HIV. If the 
cause of death was classified as code R00 - R99 (‘Symptoms, signs and 
abnormal clinical and laboratory findings not elsewhere classified’), 
other comorbid conditions were examined and if available coded as the 
primary cause of death. Patients whose final primary cause of death is 
classified as signs or symptoms (R00 - R99), heart failure, unspecified 
renal failure or malignant neoplasms of ill-defined sites are often not 
reported on individually and are classified as ‘ill-defined’ causes of 
death. We included these deaths and reported these codes to allow for 
full comparison with other publications.
HIV status was determined independently of the listed cause of 
death and comorbid conditions. Patients were classified as HIV-
positive if positive HIV status was noted in the mortuary register 
or if laboratory test results specific for HIV diagnosis or monitoring 
(e.g. HIV test, CD4+ count or viral load test) could be retrieved from 
National Health Laboratory Service records. Patients were classified 
as HIV-negative if a negative HIV test was recorded in the mortuary 
register or laboratory record (during the current admission or in 
the month prior to admission). Patients for whom HIV status could 
not be determined definitively (i.e. no positive HIV test, no HIV 
monitoring tests, and no negative HIV test during the admission 
or within the month prior to admission) were classified as having 
unknown HIV status.
Ethics approval
The study protocol was reviewed by the institutional review boards 
of the University of the Witwatersrand and Boston University, which 
approved the collection of the data without informed consent and 
the use of an anonymous analytical dataset (ref. nos M101011 and 
H-30029).
Results
Baseline description
Baseline characteristics of the study population are presented in 
Table 1. Over the 8-month period, 1 201 natural inpatient deaths met 
the study inclusion criteria. Of these, 34 had a missing admission 
date and were excluded. The final analytical cohort included 1 167 
inpatient deaths, an average of 145 deaths per month. The majority 
of inpatients who died were HIV-positive (n=682, 58%), in less than 
a third HIV status was unknown (n=343, 29%), and just over a tenth 
were confirmed HIV-negative (n=142, 12%).
There were similar numbers of males and females in the sample, 
but the rate of HIV positivity among males (55%, 331/595) was 
slightly lower than that among females (61%, 350/571), which reflects 
what is seen in the general population. The median age of the cohort 
was 46 years (interquartile range (IQR) 36 - 62), with HIV-positive 
patients younger (40 years, IQR 33 - 48) than those who were 
HIV-negative (56 years, IQR 46 - 64) and of unknown HIV status 
(68 years, IQR 53 - 79).
Fig. 1 plots inpatient mortality by age group. Mortality occurred at 
much younger ages in HIV-positive patients than in those of negative 
or unknown status. The percentage of subjects with confirmed HIV 
status (HIV-positive + HIV-negative/Total patients) fell rapidly by 
age group, with 89% of 18 - 49-year-olds having a confirmed status 
v. only 24% of those aged ≥65; in other words, patients of unknown 
HIV status were older. Similarly, known HIV positivity (confirmed 
HIV-positive/Total patients) in the cohort fell from 82% among 18 - 
49-year-olds to 10% among those aged ≥65 years.
Patients who have compromised immune systems (such as those 
with HIV and the elderly) may be more likely to be admitted and die 
during months when infectious diseases such as influenza are more 
prevalent. To explore this, mortality is plotted by calendar month of 
death and HIV status in Fig. 2. The peak of the annual severe acute 
respiratory illness (influenza) infections in 2010 occurred in July 
and August,[11] coincident with the peak of mortality in the group 
with unknown HIV status (elderly). Mortality due to influenza, 
acute lower respiratory infections and chronic respiratory infections 
showed raised rates during the months of July and August (data not 
presented). In contrast, mortality in the HIV-negative and HIV-
positive groups showed no clear seasonal patterns.
Description of causes of death
Table 2 describes the major causes of death using ICD-10 code 
chapters by HIV status. ‘Infections and parasites’ was the most 
common natural cause of death (29%), followed by ‘Respiratory’ 
(21%) and ‘Circulatory’ (17%) conditions. HIV-positive patients 
accounted for nearly 9 out of every 10 deaths related to ‘Infections 
and parasites’ (294/334), despite comprising just 58% of all deaths.
Despite ‘Infections and parasites’ accounting for 43% of deaths 
among HIV-positive patients, only one patient had HIV listed as 
the primary cause of death. The most common infectious disease 
across all groups was ‘Tuberculosis’ (A15 - A19), responsible for 19% 
of deaths overall (n=224) and nearly a third (n=204, 30%) of deaths 
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among HIV-positive patients. ‘Other heart disease’ (I30 - I52), in 
contrast, was the leading cause of death among HIV-negative patients 
(n=25, 18%) and those of unknown HIV status (n=68, 20%). Further 
details on the most common specific causes of death by broad age 
group are reported in Table 3.
In Fig. 3, distribution of mortality by major cause is illustrated 
across age groups, revealing a distinct pattern of mortality by age 
and cause, which would be expected in a population with a high 
HIV prevalence. Infectious diseases follow the same mortality profile 
as that of the HIV-positive group shown in Fig. 1, with the peak in 
the mortality in the younger age groups. Bradshaw et al.[7] dubbed 
this type of characteristic age-specific mortality profile the ‘AIDS 
signature’. Diseases of the circulatory system, which are not directly 
related to HIV, show steadily increasing mortality with increasing 
age. Respiratory disease appears more evenly spread among HIV-
positives, HIV-negatives and those with unknown HIV status (Fig. 3).
Bed days
On average, patients in the sample were admitted for 9.9 days prior 
to death. HIV-positive patients were admitted for slightly longer 
(mean 10.5 days, 95% confidence interval (CI) 9.8 - 11.3 days) than 
HIV-negative patients (9.6 days, 95% CI 8.1 - 11.1) and those of 
unknown HIV status (8.9 days, 95% CI 8.1 - 9.6). However, because 
HIV-positive inpatient deaths were more common, they accounted 
for the majority (62%) of the bed days (a proxy for resource usage) 
associated with inpatient deaths (Total HIV-positive bed days/Total 
bed days), compared with HIV-negative and HIV status unknown 
inpatient deaths (12% and 26%, respectively).
Discussion
In 2010, SA’s national ART programme was 5 years old, and >1.2 
million people were estimated to be on ART. This equated to ART 
coverage of >60% at the prevailing eligibility threshold of a CD4+ 
Table 1. Baseline characteristics of inpatient mortality
Overall (N=1 167)
HIV status
Positive (N=682) Negative (N=142) Unknown (N=343)
Gender, n (%)
Male 595 (51.0) 331 (48.5) 99 (69.7) 165 (48.1) 
Female 571 (48.9) 350 (51.3) 43 (30.3) 178 (51.9) 
Missing 1 (0.1) 1 (0.1) 0 0 
Age (years), n (%)  
18 - 19 11 (0.9) 7 (1.0) 1 (0.7) 3 (0.9) 
20 - 24 30 (2.6) 22 (3.2) 4 (2.8) 4 (1.2) 
25 - 29 81 (6.9) 65 (9.5) 7 (4.9) 9 (2.6) 
30 - 34 129 (11.1) 112 (16.4) 6 (4.2) 11 (3.2) 
35 - 39 154 (13.2) 134 (19.6) 4 (2.8) 16 (4.7) 
40 - 44 133 (11.4) 111 (16.3) 10 (7.0) 12 (3.5) 
45 - 49 117 (10.0) 86 (12.6) 12 (8.5) 19 (5.5) 
50 - 54 98 (8.4) 61 (8.9) 16 (11.3) 21 (6.1) 
55 - 59 74 (6.3) 27 (4.0) 24 (16.9) 23 (6.7) 
60 - 64 86 (7.4) 32 (4.7) 23 (16.2) 31 (9.0) 
65 - 69 69 (5.9) 19 (2.8) 19 (13.4) 31 (9.0) 
70 - 74 49 (4.2) 4 (0.6) 5 (3.5) 40 (11.7) 
75 - 79 58 (5.0) 2 (0.3) 7 (4.9) 49 (14.3) 
80 - 84 51 (4.4) 0 4 (2.8) 47 (13.7) 
85 - 89 17 (1.5) 0 0 17 (5.0) 
≥90 10 (0.9) 0 0 10 (2.9) 
Age (years), median (IQR) 46 (36 - 62) 39.5 (33 - 48) 56 (46 - 64) 68 (53 - 79) 
Length of stay (days), n (%)    
1 103 (8.8) 48 (7.0) 11 (7.7) 44 (12.8) 
2 - 5 452 (38.7) 254 (37.2) 66 (46.5) 132 (38.5) 
6 - 10 240 (20.6) 159 (23.3) 20 (14.1) 61 (17.8) 
11 - 15 133 (11.4) 75 (11.0) 13 (9.2) 45 (13.1) 
≥16 239 (20.5) 146 (21.4) 32 (22.5) 61 (17.8) 
Length of stay (days), mean (95% CI) 9.9 (9.4 - 10.5) 10.5 (9.8 - 11.3) 9.6 (8.1 - 11.1) 8.9 (8.1 - 9.6)
Month of death, n (%)    
January 92 (7.9) 53 (7.8) 16 (17.4) 23 (6.7) 
February 119 (10.2) 79 (11.6) 20 (16.8) 20 (5.8) 
March 142 (12.2) 94 (13.8) 16 (11.3) 32 (9.3) 
April 168 (14.4) 105 (15.4) 25 (14.9) 38 (11.1) 
May 147 (12.6) 102 (15.0) 21 (14.3) 24 (7.0) 
June 145 (12.4) 94 (13.8) 26 (17.9) 25 (7.3) 
July 183 (15.7) 77 (11.3) 10 (5.5) 96 (28.0) 
August 171 (14.7) 78 (11.4) 8 (4.7) 85 (24.8) 
IQR = interquartile range; CI = confidence interval.
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count <200 cells/µL.[12] Despite relatively 
high levels of access to care, however, the 
results of this study suggest that HIV-positive 
inpatient medical mortality remained high 
in 2010, with an HIV positivity of at least 
58% among all natural inpatient deaths and 
at least 82% among natural deaths between 
the ages of 18 and 49 years.
The role of HIV in inpatient mortality 
in 2010 can be compared with results of a 
similar study (W D F Venter, unpublished 
data, 2004) at the same site covering the years 
just preceding the national rollout of ART 
in SA (2000 - 2003). That study examined 
all 2 138 inpatient deaths occurring over 
3 months of each year over a 4-year period. 
A large majority (94%) were deaths due to 
natural causes, and most (75%) were from 
the medical wards, making them comparable 
to the sample in our study. The numbers of 
deaths per month and the gender and age 
distribution were similar between the two 
studies. The proportion of patients known 
to be HIV-positive more than doubled from 
20% in 2000 - 2003 to 58% in 2010. This is 
probably due in part to poor ascertainment 
of HIV status before 2004, but the large 
increase in HIV-positives could also suggest 
a real increase in the proportion of HIV-
positive deaths over this time period.
Stats SA reported that there were 28 660 
natural deaths in the City of Johannesburg 
Metropolitan Municipality in 2010.[9] Our 
sample of 1 167 therefore covers 4% (1 167/ 
28 660) of the natural deaths in Johannes-
burg that year.[9] The Stats SA report also 
notes that in Gauteng Province, where 
Johannesburg is located, ‘HIV disease’ (ICD-
10 B20 - B24) was the seventh leading cause 
of natural death, accounting for 3.4% of all 
natural deaths. This is equivalent to only 15% 
of the 21 548 deaths classified as ‘Infections 
and parasites (A00 - B99)’.[5] Our study, in 
contrast, found that 88% of all deaths classi-
fied as ‘Infections and parasites’ were among 
HIV-positive patients. If we conservatively 
assume that only those HIV-positive deaths 
classified as ‘Infections and parasites’ can be 
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Fig. 2. Inpatient mortality by calendar month of death.
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Fig. 1. Inpatient mortality by HIV status and age group.
Table 2. Cause of death (ICD-10 chapter) by HIV status
Cause of death (ICD-10 chapter)
Overall  
(N=1 167), n (%)
HIV status
Positive  
(N=682), n (%)
Negative  
(N=142), n (%)
Unknown 
(N=343), n (%)
Infections and parasites (I: A00 - B99) 334 (28.6) 294 (43.1) 9 (6.3) 31 (9.0) 
Respiratory (X: J00 - J99) 241 (20.7) 132 (19.4) 28 (19.7) 81 (23.6) 
Circulatory (IX: I00 - I99) 202 (17.3) 40 (5.9) 45 (31.7) 117 (34.1) 
Signs and symptoms (XVIII: R00 - R99) 77 (6.6) 30 (4.4) 15 (10.6) 32 (9.3) 
Nervous system (VI: G00 - G99) 61 (5.2) 45 (6.6) 7 (4.9) 9 (2.6) 
Genitourinary system (XIV: N00 - N99) 55 (4.7) 33 (4.8) 11 (7.7) 11 (3.2) 
Endocrine, nutritional and metabolic (IV: E00 - E99) 55 (4.7) 23 (3.4) 10 (7.0) 22 (6.4) 
Haematological and immune mechanism (III: D50 - D89) 48 (4.1) 40 (5.9) 2 (1.4) 6 (1.7) 
Neoplasms (II: C00 - D48) 42 (3.6) 16 (2.3) 8 (5.6) 18 (5.2) 
Digestive system (XI: K00 - K93) 34 (2.9) 20 (2.9) 5 (3.5) 9 (2.6) 
Mental and behavioural (V: F00 - F99) 11 (0.9) 5 (0.7) 2 (1.4) 4 (1.2) 
Skin and subcutaneous tissue (XII: L00 - L99) 4 (0.3) 2 (0.3) 0 2 (0.6) 
Congenital and chromosomal (XVII: Q00 - Q99) 1 (0.1) 0 0 1 (0.3) 
Factors influencing health status (XXI: Z00 - Z99) 1 (0.1) 1 (0.1) 0 0
Musculoskeletal and connective tissue (XIII: M00 - M99) 1 (0.1) 1 (0.1) 0 0
Total 1 167 (100) 682 (100) 142 (100) 343 (100)
ICD-10 = 10th revision of the International Statistical Classification of Diseases and Related Health Problems.
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directly attributed to HIV (i.e. we assume 
that 56% of deaths among HIV-positive 
patients are not caused by HIV), then 25% 
of all natural deaths in our study would be 
directly attributable to HIV, a seven-fold 
increase over the Stats SA estimate for the 
province. While deaths due to HIV may 
be over-represented in hospital admissions 
compared with the population at large, the 
largest contributor to this difference is likely 
to be under-reporting of HIV as a cause of 
death, even when the HIV status of patients 
is known.
Stats SA reported that in 2010 44% of all 
deaths occurred in hospitals, which translates 
into ~91 381 AIDS deaths in hospitals.[7,9] 
The mean length of stay associated with 
an inpatient-related HIV-positive death was 
10.5 days in our cohort, so these deaths 
could equate to ~959 500 bed days. While 
it is impossible to remove inpatient AIDS 
deaths completely, it is reasonable to assume 
that HIV-related inpatient mortality can 
be reduced substantially with earlier ART 
initiation and better treatment adherence, 
which would lessen what is currently a 
significant burden on the hospital system.
Study limitations
Our study had several limitations. As noted 
above, the mortality reported here accounts 
for only 4% of natural-cause mortality in 
the City of Johannesburg Metropolitan 
Municipality in 2010. When compared with 
national mortality statistics, however, the 
distribution by major causes of death is 
similar, which suggests that the findings 
have relevance beyond a single site. Of 
more concern is that only 70% of the sample 
had verified HIV status, and older patients 
were more likely to be of unknown HIV 
status. The mortality associated with HIV-
positive inpatients here should therefore 
be regarded as a lower boundary on true 
HIV-positive mortality, as it is likely that 
at least a few patients of unknown status 
were in fact HIV-positive. Finally, as noted 
in the ‘Methods’ section, ICD-10 codes 
were assigned based on the cause of death 
as recorded in the mortuary register. This 
did not allow for the distinction to be made 
between the underlying and immediate 
cause of death, and it is possible that 
patients may have been assigned the wrong 
cause of death.
Conclusions
We found that even with widespread access 
to ART, the majority of inpatient natural 
deaths at a large public sector hospital in 
2010 were among HIV-positive patients 
and were probably related to HIV. Our 
results provide support to the contention 
that HIV-related mortality is dramatically 
under-reported[7,8] in national statistics. 
A solution to this problem may be the 
introduction of an electronic mortuary 
register that would allow for rapid, real-time 
identification of any trends observed in the 
mortality of patients, both HIV-positive and 
HIV-negative. In view of the importance of 
accurate data on causes of death, both for 
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Fig. 3. Heart disease compared with infectious disease by age group.
Table 3. Top ten specific cause of death (ICD-10 block) by broad age category
Cause of death (ICD-10 block)
18 - 49 years (N=655), 
HIV+ = 82%
50 - 64 years (N=258), 
HIV+ = 47%
≥65 years (N=254), 
HIV+ = 10%
Rank n (%) Rank n (%) Rank n (%)
Tuberculosis (A15 - A19) 1 191 (29.2) 1 29 (11.2)  
Influenza and pneumonia (J09 - J18) 2 54 (8.2) 3 25 (9.7) 4 18 (7.1) 
Other acute lower respiratory infections (J20 - J22) 3 51 (7.8) 7 11 (4.3) 5 18 (7.1) 
Aplastic and other anaemias (D60 - D64) 4 34 (5.2)  
Inflammatory diseases of the central nervous system (G00 - G09) 5 32 (4.9)  
Intestinal infectious diseases (A00 - A09) 6 29 (4.4) 8 11 (4.3)  
Other forms of heart disease (I30 - I52) 7 26 (4.0) 2 29 (11.2) 1 57 (22.4) 
Renal failure (N17 - N19) 8 26 (4.0) 5 15 (5.8) 7 12 (4.7) 
Protozoal diseases (B50 - B64) 9 23 (3.5)  
Metabolic disorders (E70 - E90) 10 17 (2.6)  10 6 (2.4) 
Chronic lower respiratory diseases (J40 - J47)  4 18 (7.0) 2 22 (8.7) 
Hypertensive diseases (I10 - I15)  6 15 (5.8) 6 14 (5.5) 
Cerebrovascular diseases (I60 - I69) 9 10 (3.9) 3 19 (7.5) 
Diabetes mellitus (E10 - E14)  10 9 (3.5) 8 11 (4.3) 
Abnormal findings on examination of blood, without diagnosis  
(R70 - R79)
 9 8 (3.1) 
Other natural causes (not top ten)* 172 (26.2) 86 (33.3) 69 (27.2) 
All natural causes 655 (100) 258 (100) 254 (100)
ICD-10 = 10th revision of the International Statistical Classification of Diseases and Related Health Problems.
*Other natural causes that were not in the top 10 ranked ICD-10 blocks.
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HIV interventions and to track other diseases, research on this or 
other solutions is needed.
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